GP9 Antibody | 19-623

GP9 Antibody | 19-623 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Mouse

Homology: N/A

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 17-147 of human GP9 (NP_000165.1) .

Research Area: Immunology

Tested Application: WB, IF

Application: WB: 1:500 - 1:2000
IF: 1:20 - 1:100

Specificiy: N/A

Positive Control 1: U-87MG

Positive Control 2: Mouse lung

Positive Control 3: Mouse spleen

Positive Control 4: Mouse liver

Positive Control 5: Mouse skeletal muscle

Positive Control 6: N/A

Molecular Weight: Observed: 19kDa

Validation: N/A

Isoform: N/A

Purification: Affinity purification

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Concentration: N/A

Storage Condition: Store at -20˚C. Avoid freeze / thaw cycles.

Alternate Name: Platelet glycoprotein IX, GP-IX, GPIX, Glycoprotein 9, CD42a, GP9

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: This gene encodes a small membrane glycoprotein found on the surface of human platelets. It forms a 1-to-1 noncovalent complex with glycoprotein Ib, a platelet surface membrane glycoprotein complex that functions as a receptor for von Willebrand factor. The complete receptor complex includes noncovalent association of the alpha and beta subunits with the protein encoded by this gene and platelet glycoprotein V. Defects in this gene are a cause of Bernard-Soulier syndrome, also known as giant platelet disease. These patients have unusually large platelets and have a clinical bleeding tendency.